Our New Board Member, Business Immigration & Global Mobility Attorney, Shaun Staller, Works at the Core of What BABC is About
Core to the mission of BABC is the promotion of [...]
Club Level Feature – Q&A with Partners Chris Archer & Jack Sheehan
Morgan Lewis partners Chris Archer [...]
Citrin Cooperman: Understanding the One, Big, Beautiful Bill Act: Key Tax Considerations for M&A Transactions
The One, Big, Beautiful Bill Act (the “OBBBA” or the [...]
American Airlines: Philadelphia’s Gateway to the World
The start of 2025 has been memorable and exciting for [...]
Immigration Regulations & Worksite Compliance Laws
Faegre Drinker is a law firm with one shared focus: the client. We opened our doors on February 1, 2020, uniting Faegre Baker Daniels and Philadelphia-headquartered Drinker Biddle & Reath, two firms known for exceptional legal and consulting capabilities, and a commitment to service excellence.
Time is Running Out to Comply by 1/1/2025 with the new US Corporate Transparency Act (CTA) if You Own or Have Substantial Control Over a Pre-2024 Entity
Do you own or have substantial control over a U.S. entity that was in existence as of January 1, 2024 (a Pre-2024 Entity)? If so, that Pre-2024 Entity may have a NEW reporting obligation that is due on or before January 1, 2025 under the U.S. Corporate Transparency Act (CTA). The CTA is a new U.S. federal law that became effective on January 1, 2024.
A Major Milestone for Johnson Matthey’s Pennsylvania Clean Air Manufacturing Plant
Symbolising trade and investment between the United Kingdom and the surrounding South Pennsylvania region, look no further than Johnson Matthey’s Devon manufacturing plant, celebrating its 50th birthday. JM’s scientists set to work prototyping honeycomb catalysts in Europe, before patenting an autocatalyst, with a proof of concept on a 1500cc Chrysler Avenger, sold in the US as a Plymouth Cricket. Viable production followed, through combining a conveyor belt and waterfall washcoat solution, with the Devon doors opening in March 1974 - an identical replica of its Royston sibling, situated in Hertfordshire, England, UK.
Doing Business in the U.S.: What All Businesses Need to Know
Each new year brings a sense of hope, energy and opportunity. For all businesses, that means a renewed focus on growth. That often means going global. Organizations decide to be global for a combination of reasons — access to new markets; diversification; to gain a competitive edge. Sometimes an organization’s first step into an international market is at the beckoning of a leading customer's request. Indeed, the opportunity to grow top-line revenues, achieve greater economies of scale and strengthen the overall enterprise is great. However, as we look at the changing landscape of global trade, we see that it's not what globalization and global pressures will do for an organization but what it'll do to them if they don't properly prepare, plan and adapt. Baker Tilly understands change is a trigger for growth-minded organizations to evaluate their strategies and the tactics that follow. In this article we offer a road map to guide companies looking to do business in the U.S.
Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments
Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine — almost half of which are first-in-class for their indications. Becoming a hub for drug research and development took a lot more than luck. The news reached Abramson Cancer Center (ACC) Director Robert Vonderheide, MD, DPhil, at 11 a.m. on August 30, 2017. It was official: That morning, the U.S. Food and Drug Administration (FDA) approved a Penn Medicine-developed personalized cellular immune therapy. Six hours later, Vonderheide was standing atop a coffee counter in the atrium of the Perelman Center for Advanced Medicine, addressing hundreds of jubilant faculty and staff members who had gathered for a now-iconic "flash mob" celebration of the milestone. Carl June, MD, and a team of scientists, physicians, and other dedicated staff had together turned a dream of using patients’ own immune cells to treat their cancer, into a reality.
Cross Border Financial Planning USA LLC: Top 10 Financial Considerations When Moving to the U.S.
Moving to a new country is exciting. But it may also be daunting as it requires many new undertakings, such as finding a place to live or opening a bank account, which can quickly become time-consuming and frustrating. Unsurprisingly, many leave the often complex financial and legal matters for a later date. The cost of doing so, however, can be high. To save time and hardship, Cross Border Financial Planning USA has put together 10 financial matters to consider when moving to the US. Whilst this brochure focuses on the intricacies of moving from the UK to the US, many of the same or similar principles apply when moving to the US from other countries. In the UK, most people only pay tax through the Pay As You Earn (PAYE) system, whereby tax is automatically deducted from their pay cheque and often there is no need to file a tax return. Although the US tax system is also Pay As You Earn, most people are still required to file a tax return each year and it is the individual’s responsibility to make sure they do so. Another difference is that the UK tax year runs from April 6th to April 5th, whereas the US tax year follows the calendar year from January 1st to December 31st.
